El interés en corto de Molecular Templates da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Molecular Templates. Los datos de interés en corto se actualizan cada dos semanas.

Molecular Templates (NASDAQ:MTEM) Bolsa, Informe de interés en corto

Molecular Templates

Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.

Molecular Templates Inc

While &quot;the trend is your friend&quot; when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn&#39;t easy.
The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive.
Our &quot;Recent Price Strength&quot; screen, which is created on a unique short-term trading strategy, could be pretty useful in this regard. This predefined screen makes it really easy to shortlist the stocks that have enough fundamental strength to maintain their recent uptrend. Also, the screen passes only the stocks that are trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.
There are several stocks that passed through the screen:
<h2>ARS Pharmaceuticals, Inc.</h2>
(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spry#NASDAQ">SPRY</a>) is one of them. Here are the key reasons why this stock is a solid choice for &quot;trend&quot; investing.
A solid price increase over a period of 12 weeks reflects investors&#39; continued willingness to pay more for the potential upside in a stock. SPRY is quite a good fit in this regard, gaining 37.8% over this period.
However, it&#39;s not enough to look at the price change for around three months, as it doesn&#39;t reflect any trend reversal that might have happened in a shorter time frame. It&#39;s important for a potential winner to maintain the price trend. A price increase of 9.2% over the past four weeks ensures that the trend is still in place for the stock of this company.
Moreover, SPRY is currently trading at 84.9% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.
Looking at the fundamentals, the stock currently carries a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock&#39;s near-term price movements.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Another factor that confirms the company&#39;s fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock&#39;s near-term price performance.
So, the price trend in SPRY may not reverse anytime soon.
<a href="https://www.zacks.com/stock/news/2349714/ars-pharmaceuticals-inc-spry-is-on-the-move-here-s-why-the-trend-could-be-sustainable?cid=CS-BENZ-FT-tale_of_the_tape|recent_price_strength_screen-2349714">To read this article on Zacks.com click here.</a>

Biotech

Earnings

News

Small Cap

Markets

Analyst Ratings

Trading Ideas

General

SPRY

ARS Pharmaceuticals, Inc. is on the Move, Here's Why the Trend Could be Sustainable

Paycom Software's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) short percent of float has fallen 27.03% since its last report. The company recently reported that it has 2.68 million shares sold short, which is 5.56% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Paycom Software Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728933323_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Paycom Software has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Paycom Software's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Paycom Software's peer group average for short interest as a percentage of float is 6.34%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

PAYC

Looking Into Paycom Software's Recent Short Interest

General Dynamics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) short percent of float has risen 53.06% since its last report. The company recently reported that it has 3.68 million shares sold short, which is 1.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>General Dynamics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728933318_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for General Dynamics has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing General Dynamics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, General Dynamics's peer group average for short interest as a percentage of float is 2.96%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About General Dynamics?

Welltower's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WELL#NYSE">WELL</a>) short percent of float has fallen 14.02% since its last report. The company recently reported that it has 11.04 million shares sold short, which is 2.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.24 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Welltower Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1728933313_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Welltower has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Welltower's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Welltower's peer group average for short interest as a percentage of float is 7.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

WELL

Looking Into Welltower's Recent Short Interest

<a href="https://www.theinformation.com/briefings/microsoft-ai-researcher-sebastien-bubeck-to-join-openai">https://www.theinformation.com/briefings/microsoft-ai-researcher-sebastien-bubeck-to-join-openai</a>

MSFT

'Microsofts AI Researcher Sebastien Bubeck To Join OpenAI' - The Information

Fast Buds, a global producer of auto-flowering cannabis genetics, has unveiled two exclusive cultivars to mark the 2024 U.S. Presidential election. The limited-edition strains, Orange President and Kamala OG, each symbolize the contrasting political figures they are named after: former President Donald Trump and sitting Vice President Kamala Harris.
"At Fast Buds, we believe that cannabis culture thrives on creativity and conversation," says Eugene Boukreev, head of marketing at Fast Buds. "The launch of Orange President and Kamala OG is our playful way of celebrating not just the political landscape, but also the diversity and unique characteristics that reflect different perspectives."
The company views these strains as more than just a novelty. It aims to spark discussions about cannabis legalization and the political climate, while offering unique experiences to cannabis enthusiasts.
<h3 class="wp-block-heading">A Closer Look: Orange President Auto</h3>
With a head-turning appearance and effects to match, Orange President boasts a Sativa-dominant profile. Featuring vibrant orange-haired trichomes, the plant delivers potent citrus terpenes that invigorate the senses. Testing at 26% THC, the strain promises a blend of sweet, zesty citrus flavors, with uplifting effects that appeal to recreational users seeking a bright, energized high.
<h3 class="wp-block-heading">Kamala OG Auto: A Sativa For Productivity</h3>
On the other side of the political spectrum, Kamala OG is designed to be a fitting tribute to a trailblazing vice president. With a cerebral Sativa-dominant profile, Kamala OG presents a smooth balance of sweet and sour flavors, offering notes of tangy fruit cocktail. It comes in at an average of 24% THC, promising a creative, focused high for those with a busy schedule, much like its namesake.
The team describes the cultivar as a "productive and creative hybrid" that mirrors the qualities of a high-performing individual.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41314909/kamala-harris-unveils-policy-plan-for-black-men-focusing-on-economic-opportunity-health-cannabis">Kamala Harris Unveils Policy Plan For Black Men, Focusing On Economic Opportunity, Health, Cannabis Legalization</a>
<h3 class="wp-block-heading">Cannabis And Politics: A Growing Intersection</h3>
In a year where cannabis legalization has taken center stage, these strains arrive at a time of growing bipartisan support for federal legalization. According to a recent Data For Progress <a href="https://www.dataforprogress.org/blog/2024/4/20/high-support-for-legalizing-marijuana-at-the-federal-level">report</a>, 66% of U.S. voters now favor nationwide cannabis legalization, a figure that has doubled in the last two decades. Vice President Harris, in particular, has officially added cannabis legalization to her political agenda, emphasizing the importance of making it "the law of the land."
Boukreev sees the release of these strains as a reflection of the times. "Just as presidential candidates represent different views and visions, these strains offer distinct profiles and effects that allow consumers to choose what resonates with them," he explains. "Cannabis has a long history of sparking debates and bringing people together, and we wanted to blend that spirit with a bit of lighthearted fun around such an important topic."
<h3 class="wp-block-heading">Autoflower Innovation</h3>
Both strains utilize autoflowering technology, which allows cultivators to enjoy their harvest in as little as 10 weeks. Autoflower seeds, known for their ease of growth and quick flowering times, have become a favorite among both novice and experienced cannabis growers.
Pre-orders for Orange President and Kamala OG are now open on the Fast Buds website, with the official release date set for November 7, 2024. Fast Buds promises that customers will soon have the opportunity to see these cultivars in action, as community updates featuring photos and videos of the growing plants will be shared in the coming months.
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Cannabis

New Kamala OG And Orange President Cannabis Strains Celebrate 2024 Presidential Election

<a href="https://europeancapitalinsights.substack.com/p/starmer-woos-global-investors-at?r=3nmatg">British Prime Minister Keir Starmer unveiled</a> that he wants to <a href="https://www.upi.com/Top_News/World-News/2024/10/14/Starmer-pledges-red-tape-bonfire/8461728902034/">attract billions of pounds of investments</a> during his speech at a UK investment summit on Monday.&nbsp;
The inaugural International Investment Summit in London secured <a href="https://x.com/RachelReevesMP/status/1845867474161397762"> £63 billion in investments and nearly 38,000 in jobs</a>, Chancellor of the Exchequer Rachel Reeves posted on X.
The one-day summit underscored the efforts that Starmer is undertaking to revive the country's economy. <a href="https://open.substack.com/pub/europeancapitalinsights/p/british-gdp-growth-wont-offset-borrowing?r=3nmatg&amp;utm_campaign=post&amp;utm_medium=web">UK GDP grew at 0.2% in August after flatlining in June and July</a>.
Starmer <a href="https://www.gov.uk/government/speeches/pm-international-investment-summit-speech-14-october-2024">told 300 executives</a> that his government would &#8220;rip out the bureaucracy that blocks investment" by slashing red tape.&nbsp;
&#8220;Private sector investment is the way we rebuild our country and pay our way in the world," he said. "Make no mistake, this is a great moment to back Britain."
<figure class="wp-block-image is-resized"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXe4sJORXSeN3TFcQLuAZV_h0SVNljSQGu51-mrEuJrLF9cfBj8T3_S8sobDpABfGg0yJOdkf8QEqEmERVzNEy3MV7Z3lr93yrOB-x59A7hjnOXcQpXUOfXGPOTsrcxa5lZTjdcgvGAO_st8EP1EbSUMx67f?key=5dTNHPxUo5BamslZNWOJJA" alt="" style="width:624px" /></figure>
UK's Foreign Direct Investments, Source: <a href="https://www.ons.gov.uk/economy/nationalaccounts/balanceofpayments/bulletins/foreigndirectinvestmentinvolvingukcompanies/2022">Office for National Statistics</a>
<h3 class="wp-block-heading has-text-align-left">UK Summit Attracts US Data Center Providers</h3>
US firms CyrusOne, ServiceNow, Cloud HQ and CoreWeave announced as part of the summit that <a href="https://www.gov.uk/government/news/tech-secretary-welcomes-foreign-investment-in-uk-data-centres-which-will-spur-economic-growth-and-ai-innovation-in-britain">they would invest a total of £6.3 billion </a>in the country&#8217;s data infrastructure. That takes the total investment in UK data centers to over £25 billion since this government took office.
British Technology Secretary Peter Kyle welcomed the ‘vote of confidence' in Britain. 
&#8220;Tech leaders from all over the world are seeing Britain as the best place to invest with a thriving and stable market for data centers and&nbsp;AI&nbsp;development.&#8221;&nbsp;
ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) plans to invest £1.15 billion into its UK business over the next 5 years.
&#8220;AI-powered transformation is a generational opportunity,&#8221; ServiceNow Chairman and&nbsp;CEO&nbsp;Bill McDermott<a href="https://www.gov.uk/government/news/tech-secretary-welcomes-foreign-investment-in-uk-data-centres-which-will-spur-economic-growth-and-ai-innovation-in-britain"> said</a>. &#8220;ServiceNow's investment will accelerate the UK's innovation blueprint.&#8221;
<h3 class="wp-block-heading">UK Summit Secures Investments</h3>
Labour said ahead of the summit that it has secured "<a href="https://www.gov.uk/government/news/major-investment-deals-set-to-be-announced-at-governments-inaugural-international-investment-summit-as-pm-vows-to-remove-needless-regulation-declar">tens of billions worth of investments</a> within 100 days of being in office." That included more than £24 billion worth of investment in clean energy projects.
Spain's Iberdrola (OTC:<a class="ticker" href="https://www.benzinga.com/stock/IBDRY#OTC">IBDRY</a>), one of the <a href="https://open.substack.com/pub/europeancapitalinsights/p/european-energy-under-threat-from?r=lo563&amp;utm_campaign=post&amp;utm_medium=web">biggest energy companies in Europe</a>, doubled its investment in the UK to £24 billion. Denmark's Orsted (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DOGEF#OTC">DOGEF</a>) unlocked £8bn and GreenVolt £2.5bn of investment in offshore wind farms.&nbsp;
But confidence in the economy has been hurt by social tensions around illegal immigration and uncertainty about the upcoming budget. An escalation in <a href="https://open.substack.com/pub/europeancapitalinsights/p/geopolitical-risks-may-be-biggest?r=lo563&amp;utm_campaign=post&amp;utm_medium=web">geopolitical tensions in the Middle East</a> has undermined sentiment.
Starmer's and Reeve's popularity has fallen steeply since they won elections in July. In September, consumer confidence crashed by the most in two-and-a-half years.&nbsp;
The <a href="https://www.benzinga.com/topic/uk-ftse-100">FTSE 100</a> traded flat after Starmer's speech. <a href="https://tradingeconomics.com/united-kingdom/calendar">With UK jobs data due</a> out Tuesday and&nbsp; inflation on Wednesday, markets focused on <a href="https://uk.finance.yahoo.com/news/live/ftse-100-live-european-stock-markets-wall-street-082512903.html">key economic data</a>.
<figure class="wp-block-image is-resized"><img decoding="async" src="https://lh7-rt.googleusercontent.com/docsz/AD_4nXc7GAESCPICv80hwMEA0uw7nohPbwd8Y0EWU_l31h92d8G5y2s4KU045BXLrdhTwsPhT9y52oiTrGTM1q5HRatDIXncz5IO5Vj0nv_HrcbYAOpE13L0chKRYT_CKZATy1zv0uaZJYNiY9ugSBRGp_GT7F4U?key=5dTNHPxUo5BamslZNWOJJA" alt="" style="width:624px" /></figure>
FTSE 100 Performance Year-to-date, Source: TradingView
<h3 class="wp-block-heading">UK Summit Gets Support From Banks</h3>
Ahead of the UK summit, some of the world's biggest banks and companies offered an upbeat message. In a letter to The Times, five of the world's biggest banks joined private ­equity firms, insurers and tech giants to say it was "<a href="https://www.thetimes.com/article/89afda46-2ced-481c-b4a0-0da65d2a6a1e?shareToken=206261895595c2ed7be6fe2d7796544e">time to invest in Britain</a>."
<a href="https://www.thetimes.com/article/89afda46-2ced-481c-b4a0-0da65d2a6a1e?shareToken=206261895595c2ed7be6fe2d7796544e">The 14 signatories</a> include JPMorgan, Goldman Sachs, Bank of America, Citigroup and UBS. Insurers Aviva and L&amp;G signed the letter, alongside private equity firms including Blackstone and KKR.
They pointed to stability, universities, legal expertise and financial services already providing the "bedrock of a strong investment proposition." Growth in the technology and energy sectors had "further enhanced Britain's position."
Confirmed speakers included Ruth Porat, President &amp; Chief Investment Officer of Alphabet and David A. Ricks Chair and CEO of Eli Lilly. Alex Kendall, CEO of Wayve, and Pushmeet Kohli Vice President of Research at <a href="https://widgets.benzinga.com/topic/deepmind">Google DeepMind</a>, were confirmed to attend.
Some participants, though, expressed frustration about the <a href="https://www.cnbc.com/2024/10/14/uk-international-investment-summit-labour-woos-new-business-to-britain.html">lack of information surrounding the summit</a>, CNBC reported. Many multinational executives and tech leaders declined to attend or weren't invited. The Financial Times partly attributed the summit&#8217;s turnout to <a href="https://www.france24.com/en/live-news/20241014-starmer-vows-to-cut-red-tape-as-he-urges-foreign-investors-to-back-uk">concerns over its &#8220;quality and organization</a>."
<h3 class="wp-block-heading">UK Summit Undermined By Musk Controversy</h3>
Critics have also questioned the Labour Party's decision not to invite billionaire Elon Musk to the UK summit.&nbsp;
"Extraordinary failure by the UK government to exclude @elonmusk&nbsp; from the UK Business Summit," James McMurdock, a Reform UK MP, wrote on X. "His absence is a blow to Britain's future and growth potential. We should be engaging with global innovators, not sidelining them."
Technology Secretary <a href="https://www.independent.co.uk/topic/peter-kyle">Peter Kyle</a> denied Musk had been snubbed. But British Business Secretary Jonathan Reynolds failed to provide a clear answer as to why Musk wasn't invited.
"I am not going to comment on the reasons for any specific person," he said during an interview on SkyNews. "If people have an investment proposition for the UK, I will talk to them about it."
<h3 class="wp-block-heading">Musk Hits Back After UK Submit Snub</h3>
Musk hit back after not being invited. &#8220;I don't think anyone should go to the UK when they're releasing convicted pedophiles in order to imprison people for social media posts,&#8221; Musk posted on X.
He was apparently referring to the <a href="https://www.msn.com/en-in/news/uknews/britain-hosts-an-international-investment-summit-and-denies-snubbing-elon-musk/ar-AA1seBzA">government's decision to release hundreds of inmates</a> — though not sex offenders — early because of overcrowded prisons, the Independent reported.
Musk has clashed with British officials about their crackdown on free speech.&nbsp;
The tech billionaire posted a comment on X saying that "Civil war is inevitable" in the UK.&nbsp;
Justice Minister Heidi Alexander said that using language such as "civil war" was unacceptable.&nbsp;&nbsp;
Disclaimer
Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.
This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content&nbsp;or&nbsp;accuracy.

DOGEF

IBDRY

Starmer Woos Global Investors At UK Summit

While &quot;the trend is your friend&quot; when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the sustainability of a trend isn&#39;t easy.
The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive.
Our &quot;Recent Price Strength&quot; screen, which is created on a unique short-term trading strategy, could be pretty useful in this regard. This predefined screen makes it really easy to shortlist the stocks that have enough fundamental strength to maintain their recent uptrend. Also, the screen passes only the stocks that are trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.
There are several stocks that passed through the screen:
<h2>Brady</h2>
(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/brc#NYSE">BRC</a>) is one of them. Here are the key reasons why this stock is a solid choice for &quot;trend&quot; investing.
A solid price increase over a period of 12 weeks reflects investors&#39; continued willingness to pay more for the potential upside in a stock. BRC is quite a good fit in this regard, gaining 7.5% over this period.
However, it&#39;s not enough to look at the price change for around three months, as it doesn&#39;t reflect any trend reversal that might have happened in a shorter time frame. It&#39;s important for a potential winner to maintain the price trend. A price increase of 0.5% over the past four weeks ensures that the trend is still in place for the stock of this identification and security products maker.
Moreover, BRC is currently trading at 92.2% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.
Looking at the fundamentals, the stock currently carries a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock&#39;s near-term price movements.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Another factor that confirms the company&#39;s fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock&#39;s near-term price performance.
So, the price trend in BRC may not reverse anytime soon.
<a href="https://www.zacks.com/stock/news/2349713/brady-brc-is-a-great-choice-for-trend-investors-here-s-why?cid=CS-BENZ-FT-tale_of_the_tape|recent_price_strength_screen-2349713">To read this article on Zacks.com click here.</a>

Mid Cap

Brady Is a Great Choice for 'Trend' Investors, Here's Why

Legendary investor Warren Buffett has built Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) into one of the most valuable companies in the world through a series of acquisitions and investments over the years, making the man known as the &#8220;Oracle of Omaha&#8221; one of the <a href="https://www.benzinga.com/general/movers-shakers/21/08/17298128/warren-buffett-turns-91-a-highlight-for-each-decade-of-his-life-1">most followed stock pickers.</a>
Buffett&#8217;s investments have paid off, with Berkshire Hathaway recently <a href="https://www.benzinga.com/top-stories/24/08/40604676/warren-buffetts-berkshire-hathaway-breaks-1-trillion-poll-points-to-big-pharma-not-tech-as-next-cont">joining the $1 trillion</a> market capitalization club. Investors who bought Berkshire Hathaway shares or followed Buffett's stock picks have done quite well over the years.
One area where following Buffett wouldn&#8217;t have paid off for investors is cryptocurrency.
What Happened: Leading cryptocurrency Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) hit <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37498047/exclusive-bitcoin-hits-new-all-time-high-heres-when-benzinga-readers-think-100k-milestone-">new all-time highs </a>of $73,750.07 in March.
While Bitcoin is down from all-time highs, the leading cryptocurrency is up 42.8% year-to-date in 2024 and up over 130% in the last year, moves celebrated by the crypto community.
One person likely not celebrating the move is Buffett, who is among<a href="https://www.benzinga.com/markets/cryptocurrency/22/04/26538722/warren-buffett-is-bitcoin-enemy-no-1-a-sociopathic-grandpa-from-omaha-says-peter-thiel" target="_blank" rel="noreferrer noopener">&nbsp;the leading vocal critics&nbsp;</a>of the cryptocurrency sector.
Buffett&#8217;s bearish take on Bitcoin led him to previously be labeled as Bitcoin&#8217;s enemy number one by entrepreneur Peter Thiel.
In January 2018, Buffett warned investors about investing in cryptocurrency.
&#8220;In terms of cryptocurrencies, generally, I can say with almost certainty that they come with a bad ending,&#8221; Buffett said at the time. &#8220;If I could buy a five-year put on every one of the cryptocurrencies, I&#8217;d be glad to do it but I would never short a dime&#8217;s worth.&#8221;
A few months later, Buffett took his feelings on Bitcoin further during an interview with&nbsp;<a href="https://www.cnbc.com/2018/05/05/warren-buffett-says-bitcoin-is-probably-rat-poison-squared.html" target="_blank" rel="noreferrer noopener">CNBC</a>.
Buffett also reiterated the thoughts of the late Berkshire Vice Chairman&nbsp;Charlie Munger&nbsp;that Bitcoin is &#8220;rat poison.&#8221; He later told CNBC anchor&nbsp;Becky Quick&nbsp;that cryptocurrency is &#8220;probably rat poison squared.&#8221;
The legendary investor has not bought cryptocurrencies directly and continues to speak out against the sector.&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/22/05/27208096/warren-buffett-now-owns-bitcoin-heres-how-the-oracle-of-omaha-got-exposure-3" target="_blank" rel="noreferrer noopener">Benzinga previously reported</a>&nbsp;that Buffett and Berkshire are shareholders in&nbsp;Nu Holdings&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), a crypto-friendly digital bank in Brazil. Nu Holdings has also launched several cryptocurrency products.
Nu Holdings also said previously it would allocate a portion of its cash to Bitcoin.
At the time of writing, Bitcoin has a market capitalization of $1.3 trillion. Berkshire Hathaway is valued at around $992 billion. Bitcoin is currently worth more than Buffett&#8217;s company.
Here&#8217;s a look at how investors in Bitcoin would have done since Buffett&#8217;s comments.
You may not be a billionaire like Warren Buffett, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/general/entertainment/24/10/41187322/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">check out five stocks flying under the radar that deserve your attention.</a>
Investing $1,000 in Bitcoin:&nbsp;While Buffett said he wouldn&#8217;t invest in Bitcoin and used the &#8220;rat poison squared&#8221; comparison, others may have disagreed and chosen to allocate a portion of their investments or holdings in the leading cryptocurrency.
Bitcoin traded between $9,695.12 and $9,964.50 on May 5, 2018 – the day of Buffett&#8217;s &#8220;rat poison squared&#8221; comment.
An investor could have purchased 0.1004 BTC at the coin&#8217;s high price of that day.
The $1,000 investment would be worth $6,600.38 today, based on a price of $65,740.81 for Bitcoin at the time of writing. This represents a return of 560.0% since Buffett&#8217;s comments.
For comparison, a $1,000 investment in Berkshire Hathaway could have bought 0.0034 BRK-A shares at the same time. The $1,000 investment would be worth $2,348.18 today, up 134.8%.
A $1,000 investment in the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which tracks the S&amp;P 500 Index, could have bought 3.75 shares of the popular ETF at the time of Buffett&#8217;s comments. The $1,000 investment would be worth $2,192.06 today, up 119.2%.
As investors can see, Bitcoin has outperformed both the S&amp;P 500 and Berkshire Hathaway since Buffett&#8217;s now famous quote about the leading cryptocurrency.
Buffett has said he wouldn&#8217;t touch Bitcoin even if it hit $25 per coin. However, those who bought the apex crypto when the legendary investor made his statement would be glad that they did.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41255580/satoshi-nakamoto-identity-remains-a-mystery-after-hbo-documentary-bronze-statue-celebrates">Satoshi Nakamoto Identity Remains A Mystery After HBO Documentary: Bronze Statue Celebrates Bitcoin Founder&#8217;s Anonymity – &#8216;We Are All Satoshi&#8217;</a></li>
</ul>
This article was previously published by Benzinga and has been updated.
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Education

$BTC

If You Invested $1,000 In Bitcoin When Warren Buffett Called It 'Rat Poison Squared,' Here's How Much You'd Have Today

<a href="https://www.reuters.com/technology/artificial-intelligence/google-buy-power-small-modular-nuclear-reactor-company-kairos-ai-needs-2024-10-14/#:~:text=WASHINGTON%2C%20Oct%2014%20(Reuters),electricity%20demand%20from%20artificial%20intelligence.">https://www.reuters.com/technology/artificial-intelligence/google-buy-power-small-modular-nuclear-reactor-company-kairos-ai-needs-2024-10-14/#:~:text=WASHINGTON%2C%20Oct%2014%20(Reuters),electricity%20demand%20from%20artificial%20intelligence.</a>
&nbsp;
Alphabet's <a href="https://www.reuters.com/markets/companies/GOOGL.O">(GOOGL.O), opens new tab</a> Google said on Monday it signed the world's first corporate agreement to buy power from multiple small modular reactors as the technology company looks to meet electricity demand from artificial intelligence.
The agreement with Kairos Power aims to bring Kairos' first small modular reactor online by 2030, followed by additional deployments through 2035.
The companies did not reveal financial details of the agreement or where in the U.S. the plants would be built. Google said it has agreed to buy 500 megawatts of power from six to seven reactors, which is smaller than the output of today's nuclear reactors.
"We feel like nuclear can play an important role in helping to meet our demand ... cleanly in a way that's more around the clock," Michael Terrell, senior director for energy and climate at Google, told reporters on a call.
Technology firms have signed several recent agreements with nuclear power companies this year as artificial intelligence boosts power demand for the first time in decades.
In March, Amazon.com <a href="https://www.reuters.com/markets/companies/AMZN.O">(AMZN.O), opens new tab</a> <a href="https://www.reuters.com/markets/deals/talen-asks-us-regulators-reject-challenge-amazon-data-center-deal-2024-07-05/">purchased</a> a nuclear-powered datacenter from Talen Energy <a href="https://www.reuters.com/markets/companies/TLN.O">(TLN.O), opens new tab</a>. Last month, Microsoft <a href="https://www.reuters.com/markets/companies/MSFT.O">(MSFT.O), opens new tab</a> and Constellation Energy <a href="https://www.reuters.com/markets/companies/CEG.O">(CEG.O), opens new tab</a> <a href="https://www.reuters.com/markets/deals/constellation-inks-power-supply-deal-with-microsoft-2024-09-20/">signed a power deal</a> to help resurrect a unit of the Three Mile Island plant in Pennsylvania, the site of the worst U.S. nuclear accident in 1979.
U.S. data center power use is expected to roughly triple between 2023 and 2030 and will require about 47 gigawatts of new generation capacity, according to Goldman Sachs estimates, which assumed natural gas, wind and solar power would fill the gap.
The Google deal will depend on Kairos getting full permitting from the U.S. Nuclear Regulatory Commission and local agencies.
Kairos late last year got a construction permit from the NRC to build a demonstration reactor in Tennessee. But Kairos needs design and construction permits from the NRC for the reactors in the deal announced on Monday.
Small modular reactors are intended to be smaller than today's reactors with components built in a factory, instead of onsite, to help cut construction costs.
Critics say SMRs will be expensive because they may not be able to achieve the economy of scale of larger plants. In addition, they will likely produce long-lasting nuclear waste for which the country does not yet have a final repository.
Google said by committing to a so-called order book framework with Kairos, instead of buying one reactor at a time, it is sending a demand signal to the market and making a long-term investment to speed development of SMRs.
&nbsp;
"We're confident that this novel approach is going to improve the prospects of our projects being delivered on cost and on schedule," said Mike Laufer, CEO and co-founder of Kairos.

GOOG

GOOGL

Alphabet's Google Says Signs Deal To Buy Nuclear Power From Small Modular Reactors To Be Developed By Kairos Power; Alphabet And Kairos Say Deal Is For 500 Megawatts Of Power From SMRS; Agreement Intends To Bring Kairos Power's First SMR Online By 2030, With More Deployments Through 2035

U.S. stocks traded higher toward the end of trading, with the S&amp;P 500 gaining around 0.8% on Monday.
The Dow traded up 0.53% to 43,092.98 while the NASDAQ rose 0.94% to 18,515.33. The S&amp;P 500 also rose, gaining, 0.82% to 5,862.96.
Check This Out: <a href="https://www.benzinga.com/news/24/10/41308141/this-analyst-with-85-accuracy-rate-sees-around-20-upside-in-amd-here-are-5-stock-picks-for-last-week">This Analyst With 85% Accuracy Rate Sees Around 20% Upside In AMD &#8211; Here Are 5 Stock Picks For Last Week From Wall Street&#8217;s Most Accurate Analysts</a>
Leading and Lagging Sectors Information technology shares jumped by 1.4% on Monday.
In trading on Monday, energy shares fell by 0.1%.
Top Headline
Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) announced the release of its Truth+ streaming service on the web.
Truth+ streaming service's content ranges from entertainment, news and faith-based programming to documentaries and weather. Apart from the web, users can access it via an Android app.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Tevogen Bio Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) shares shot up 161% to $0.9910. Tevogen Bio plans to share $1 billion + revenue potential of its pipeline portfolio beginning week of Oct. 14.</li>
<li>Shares of Verb Technology Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERB#NASDAQ">VERB</a>) got a boost, surging 70% to $13.40 after the CEO, in a letter to shareholders, highlighted the company's cash balance and implied the stock is undervalued. CEO Rory J. Cutaia started off the letter to shareholders highlighting key pieces of financial data related to Verb. Specifically, Cutaia highlighted the company's market cap of $3.8 million as October 10 and its cash balance of $17.2 million as of the its last Form 10-Q filing.</li>
<li>Longboard Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBPH#NASDAQ">LBPH</a>) shares were also up, gaining 51% to $58.83 after the company announced it will be acquired by Lundbeck.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Molecular Templates, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares dropped 75% to $0.3749 after the company announced it approved the liquidation and wind-up of the company.</li>
<li>Shares of Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) were down 15% to $2.0450. The commodity has been weighed down this year by an oversupply.</li>
<li>Vicinity Motor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEV#NASDAQ">VEV</a>) was down, falling 34% to $0.0778 after the company announced it has not been successful renegotiating terms with Royal Bank of Canada or Export Development Canada.</li>
</ul>
Commodities In commodity news, oil traded down 1.8% to $74.18 while gold traded down 0.4% at $2,666.00.
Silver traded down 1.2% to $31.36 on Monday, while copper fell 2.3% to $4.3920.
Euro zone
European shares closed higher today. The eurozone's STOXX 600 gained 0.53%, Germany's DAX gained 0.69% and France's CAC 40 rose 0.32%. Spain's IBEX 35 Index rose 1.12%, while London's FTSE 100 rose 0.47%.
Asia Pacific Markets
Asian markets closed mostly higher on Monday, with Hong Kong's Hang Seng Index falling 0.75%, China's Shanghai Composite Index gaining 2.07% and India's BSE Sensex gaining 0.73%.
Economics
No major economic reports are scheduled for release today.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41310728/top-2-utilities-stocks-that-may-jump-this-month">Top 2 Utilities Stocks That May Jump This Month</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

LBPH

MTEM

TVGN

VERB

Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump

Ethereum Classic (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/etc/usd">ETC</a>) is trading higher by 5.17% to $19.49 Monday afternoon amid a broader surge in the cryptocurrency market, notably in Bitcoin and Ethereum <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41313376/bitcoin-closes-in-on-65k-as-etfs-see-over-400m-in-net-inflows">exchange-traded funds (ETFs)</a>.
This uptick follows last week's political developments in the U.S., where a perceived shift toward Republican leadership—considered more crypto-friendly—boosted inflows into Bitcoin and Ethereum-related products, totaling $407 million.
What&#8217;s Happening: The primary catalyst behind this surge was the U.S. vice presidential debate, where subsequent polling indicated growing support for the Republican Party. This political environment, perceived as favorable to cryptocurrency adoption and regulation, overshadowed macroeconomic factors, according to analysts. 
While Bitcoin and Ethereum were the main beneficiaries, Ethereum Classic has also gained traction as investors seek exposure to the broader blockchain space beyond the top two digital assets.
Ethereum Classic, an altcoin that shares its origins with Ethereum but exists on a separate chain due to a hard fork in 2016, has historically benefited during periods of heightened interest in its larger counterparts.
Stock Of The Day: <a href="https://www.benzinga.com/trading-ideas/technicals/24/10/41316208/stock-of-the-day-boeing-stock-sells-off-as-support-collapses-job-cuts-loom">Boeing Stock Sells Off As Support Collapses, Job Cuts Loom</a>
The reasoning is clear: when Bitcoin and Ethereum see significant inflows and price increases, alternative cryptocurrencies like ETC often rally due to speculative interest, portfolio diversification, and renewed attention on projects with lower market capitalizations.
What Else: The spillover effect from Bitcoin&#8217;s $419 million inflows and Ethereum&#8217;s smaller but significant participation, even amid its own outflows, has lifted sentiment across the altcoin market. 
Ethereum Classic, as a lower-cost alternative with strong historical ties to Ethereum, has attracted new buyers. This is especially true for investors seeking cheaper entry points in the evolving crypto market.
Additionally, the rise in blockchain equity ETFs, which saw their largest weekly inflows of the year at $34 million, further signals renewed optimism across the broader crypto ecosystem.
Investors are betting on long-term growth and development in blockchain technology, and Ethereum Classic, with its emphasis on immutability and decentralization, remains a key player in this narrative.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41317881/hurricane-milton-to-deliver-2-5b-blow-to-floridas-homebuilding-sector-goldman-sachs">Hurricane Milton To Deliver $2.5B Blow To Florida&#8217;s Homebuilding Sector, Goldman Sachs Says</a>

$ETC

Why Ethereum Classic (ETC) Is Rising

<a href="https://www.federalreserve.gov/newsevents/speech/waller20241014a.htm" title="https://www.federalreserve.gov/newsevents/speech/waller20241014a.htm">https://www.federalreserve.gov/newsevents/speech/waller20241014a.htm</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Waller Says Hurricanes, Boeing Strike May Reduce Oct Payrolls Growth By 100,000; Looking Ahead, Expect Payroll Gains To Moderate, Unemployment Rate To Drift Higher But Stay Historically Low; Watching Inflation Data To See How Persistent Recent Uptick Is; Progress On Inflation Has Been 'Rollercoaster'

Most of us have heard the dictum &quot;the trend is your friend.&quot; And this is undeniably the key to success when it comes to short-term investing or trading. But it isn&#39;t easy to ensure the sustainability of a trend and profit from it.
Often, the direction of a stock&#39;s price movement reverses quickly after taking a position in it, making investors incur a short-term capital loss. So, it&#39;s important to ensure that there are enough factors -- such as sound fundamentals, positive earnings estimate revisions, etc. -- that could keep the momentum in the stock going.
Investors looking to make a profit from stocks that are currently on the move may find our &quot;Recent Price Strength&quot; screen pretty useful. This predefined screen comes handy in spotting stocks that are on an uptrend backed by strength in their fundamentals, and trading in the upper portion of their 52-week high-low range, which is usually an indicator of bullishness.
<h2>Enliven Therapeutics, Inc.</h2>
(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/elvn#NASDAQ">ELVN</a>) is one of the several suitable candidates that passed through the screen. Here are the key reasons why it could be a profitable bet for &quot;trend&quot; investors.
A solid price increase over a period of 12 weeks reflects investors&#39; continued willingness to pay more for the potential upside in a stock. ELVN is quite a good fit in this regard, gaining 26.8% over this period.
However, it&#39;s not enough to look at the price change for around three months, as it doesn&#39;t reflect any trend reversal that might have happened in a shorter time frame. It&#39;s important for a potential winner to maintain the price trend. A price increase of 25.1% over the past four weeks ensures that the trend is still in place for the stock of this company.
Moreover, ELVN is currently trading at 96.2% of its 52-week High-Low Range, hinting that it can be on the verge of a breakout.
Looking at the fundamentals, the stock currently carries a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises -- the key factors that impact a stock&#39;s near-term price movements.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988.
Another factor that confirms the company&#39;s fundamental strength is its Average Broker Recommendation of #1 (Strong Buy). This indicates that the brokerage community is highly optimistic about the stock&#39;s near-term price performance.
So, the price trend in ELVN may not reverse anytime soon.
<a href="https://www.zacks.com/stock/news/2349711/enliven-therapeutics-inc-elvn-is-a-great-choice-for-trend-investors-here-s-why?cid=CS-BENZ-FT-tale_of_the_tape|recent_price_strength_screen-2349711">To read this article on Zacks.com click here.</a>

ELVN

Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why

Fed's Waller Says If Inflation Unexpectedly Rises, Fed Could Pause Rate Cuts; Latest Inflation Data 'Disappointing'; Economy On Solid Footing, May Not Be Slowing As Much As Desired; Expect Gdp To Grow Faster In 2h 2024; Household Resources For Future Consumption 'In Good Shape'; Waller Sees Pent-up Demand For Big-ticket Items, Consumers 'eager' To Make Purchases As Rates Come Down; Labor Market 'Quite Healthy,' Labor Supply And Demand Have Come Into Balance

Over the past 24 hours, BNB's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) price has risen 3.56% to $588.4. This continues its positive trend over the past week where it has experienced a 3.0% gain, moving from $571.9 to its current price. As it stands right now, the coin's all-time high is $717.48. 
The chart below compares the price movement and volatility for BNB over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1728932622_0.png" alt="price_chart" />
BNB's trading volume has climbed 17.0% over the past week, moving in tandem, directionally, with the overall circulating supply of the coin, which has increased 0.05%. This brings the circulating supply to 145.89 million, which makes up an estimated 72.94% of its max supply of 200.00 million. According to our data, the current market cap ranking for BNB is #4 at $85.84 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1728932622_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

$BNB

BNB's Price Increased More Than 3% Within 24 hours

Fed's Waller Says Fed Should Proceed With More Caution On Rate Cuts Than Was Needed At Sept Meeting; My Baseline Calls For Reducing Policy Rate Gradually Over The Next Year;  Policy Rate Is Currently Restrictive; If Economy Proceeds As Expected, Can Move Policy To A Neutral Stance At 'Deliberate Pace'; If, In A Less Likely Case, Inflation Falls Below 2% Or Labor Market Deteriorates, Fed Can Front-Load Rate Cuts

On-chain analytics data Lookonchain highlighted a crypto whale's 4,000% return on an investment in the <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41318708/memecoin-supercycle-analyst-shares-his-top-10-meme-picks-one-is-a-pre-pump-shiba-inu">SPX6900 meme coin. </a>
What Happened: The trader initially <a href="https://x.com/lookonchain/status/1845665350349918278">spent</a> $161,000 to purchase 7.79 million SPX two months ago. The trader has sold 638,000 SPX, earning $562,000 at $0.88 per SPX, leaving 7.15 million SPX worth $6 million. 
The trader&#8217;s total profit is $6.4 million, a 40x return on their initial investment. Over the past seven days, SPX is up 85.8% gains. The meme coin has surged 2,829.5% over the past month.
This significant return on investment underscores the potential profitability of strategic trading in the volatile cryptocurrency market. The investor&#8217;s strategy of buying low and selling high has paid off handsomely.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41318708/memecoin-supercycle-analyst-shares-his-top-10-meme-picks-one-is-a-pre-pump-shiba-inu">&#8216;Memecoin Supercycle&#8217; Analyst Shares His Top 10 Meme Picks—One Is A &#8216;Pre-Pump&#8217; Shiba Inu</a>
Why It Matters: The success of this whale investor could inspire other traders to adopt similar strategies, potentially leading to increased market activity and volatility. However, it&#8217;s important to note that such high returns are not guaranteed and investing in cryptocurrencies carries significant risk.
Crypto trader Murad pulled off a similar feat, having <a href="https://x.com/followin_io/status/1845019760502907034">purchased</a> SPX four months ago for a 7,900% return to date. He purchased 10.25 million SPX at an average price of around $0.0096, worth $98,000.
Based on current prices, Murad's holdings are worth around $7.89 million with an unrealized profit of around $7.79 million. The meme coin's valuation currently stands at $753.9 million, up from around $25 million a month ago.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41214724/memecoin-supercycle-means-best-tokens-are-cults-says-analyst-do-dogecoin-and-shiba-inu-fit">&#8216;Memecoin Supercycle&#8217; Means Best Tokens Are Cults, Says Analyst: Do Dogecoin And Shiba Inu Fit The Bill?</a></li>
</ul>
Image: Shutterstock

Trader Turns $161K Into $6.4M In Only 1 Month With This Meme Coin Parodying The S&P 500

Over the past 24 hours, NEAR Protocol's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/near/usd">NEAR</a>) price has risen 9.25% to $5.01. This is contrary to its negative trend over the past week where it has experienced a 4.0% loss, moving from $5.21 to its current price. As it stands right now, the coin's all-time high is $20.44. 
The chart below compares the price movement and volatility for NEAR Protocol over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1728932553_0.png" alt="price_chart" />
The trading volume for the coin has tumbled 23.0% over the past week while the circulating supply of the coin has risen 9.97%. This brings the circulating supply to 1.21 billion. According to our data, the current market cap ranking for NEAR is #23 at $6.09 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1728932553_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$NEAR

Cryptocurrency NEAR Protocol Rises More Than 9% In 24 hours

Dogecoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) price has increased 4.98% over the past 24 hours to $0.11. Over the past week, DOGE has experienced an uptick of over 4.0%, moving from $0.11 to its current price. As it stands right now, the coin's all-time high is $0.73. 
The chart below compares the price movement and volatility for Dogecoin over the past 24 hours (left) to its price movement over the past week (right). The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.
<img src="https://www.benzinga.com/files/images/story/2024/1728932544_0.png" alt="price_chart" />
The trading volume for the coin has climbed 1.0% over the past week, moving opposite, directionally, with the overall circulating supply of the coin, which has decreased 0.2%. This brings the circulating supply to 146.30 billion. According to our data, the current market cap ranking for DOGE is #9 at $16.82 billion.
<img src="https://www.benzinga.com/files/images/story/2024/1728932544_1.png" alt="supply_and_vol" />
<a href="https://www.coingecko.com/en/api">Powered by CoinGecko API</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$DOGE

Dogecoin's Price Increased More Than 4% Within 24 hours

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Molecular Templates (NASDAQ:<a href="https://investorplace.com/stock-quotes/mtem-stock-quote/">MTEM</a>) just reported results for the fourth quarter of 2023.<ul><li>Molecular Templates reported earnings per share of -73 cents. This was above the analyst estimate for EPS of -97 cents.</li><li>The company reported revenue of $7.02 million.</li><li>This was 9.70% worse than the analyst estimate for revenue of $7.77 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/mtem-stock-earnings-molecular-templates-for-q4-of-2023/">MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MTEM Stock Earnings: Molecular Templates Beats EPS, Misses Revenue for Q4 2023

Molecular Templates Inc (MTEM) has shared an announcement. Molecular Templates, Inc. is cutting its workforce by 30% to conserve resources and sust...

Molecular Templates Inc Announces Layoffs, CMO Resignation

Molecular Templates files to sell 11.01M common shares for holders

Molecular Templates GAAP EPS of $0.08, revenue of $11.09M beats by $5.19M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Molecular Templates (NASDAQ:<a href="https://investorplace.com/stock-quotes/mtem-stock-quote/">MTEM</a>) just reported results for the first quarter of 2024.<ul><li>Molecular Templates reported earnings per share of 8 cents. This was above the analyst estimate for EPS of -78 cents.</li><li>The company reported revenue of $11.09 million.</li><li>This was 87.90% better than the analyst estimate for revenue of $5.90 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/mtem-stock-earnings-molecular-templates-for-q1-of-2024/">MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!



Moving stocks this morning are earnings reports, new contracts, a CEO change and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Cue Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/hlth-stock-quote/">HLTH</a>) stock is rocketing more than 49% despite <a href="https://investorplace.com/2024/05/why-is-cue-health-hlth-stock-down-40-today/">plans to close its business</a>.</li>



<li>Smart for Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/smfl-stock-quote/">SMFL</a>) shares are soaring over 48% after <a href="https://www.nasdaq.com/press-release/smart-for-life-announces-updates-on-successful-completion-of-restructuring-program">completing a restructuring program</a>.</li>



<li>Molecular Templates (NASDAQ:<a href="https://investorplace.com/stock-quotes/mtem-stock-quote/">MTEM</a>) stock is surging more than 30% without any clear news this morning.</li>



<li>OneMedNet (NASDAQ:<a href="https://investorplace.com/stock-quotes/onmd-stock-quote/">ONMD</a>) shares are increasing over 29% after <a href="https://finance.yahoo.com/news/onemednet-inks-agreement-global-top-200500512.html">signing a new contract</a>.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) stock is rising more than 26% alongside heavy pre-market trading.</li>



<li>Cheche (NASDAQ:<a href="https://investorplace.com/stock-quotes/ccg-stock-quote/">CCG</a>) shares are gaining over 21% with its <a href="https://www-thailand--business--news-com.webpkgcache.com/doc/-/s/www.thailand-business-news.com/thailand-prnews/cheche-group-reports-first-quarter-2024-unaudited-financial-results">latest earnings release</a>.</li>



<li>Verb Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>) stock is climbing more than 17% with strong early morning trading.</li>



<li>Nexalin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxl-stock-quote/">NXL</a>) shares are jumping over 15% despite a lack of news.</li>



<li>Burlington Stores (NYSE:<a href="https://investorplace.com/stock-quotes/burl-stock-quote/">BURL</a>) stock is getting a more than 14% boost with its <a href="https://finance.yahoo.com/news/burlington-stores-inc-reports-first-104500806.html">Q1 earnings report</a>.</li>



<li>C3.ai (NYSE:<a href="https://investorplace.com/stock-quotes/ai-stock-quote/">AI</a>) shares are up over 14% after <a href="https://www.investors.com/news/technology/c3-ai-stock-ai-stock-c3-ai-earnings-news-q12024/">beating Q1 estimates</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is plummeting more than 40% alongside <a href="https://www.nasdaq.com/press-release/novabay-pharmaceuticals-announces-approval-all-proposals-its-2024-annual-meeting">annual shareholder meeting plans</a>.</li>



<li>UiPath (NYSE:<a href="https://investorplace.com/stock-quotes/path-stock-quote/">PATH</a>) shares are diving over 30% on <a href="https://www.nasdaq.com/press-release/uipath-re-appoint-daniel-dines-chief-executive-officer-rob-enslin-steps-down-ceo-and">a CEO change</a>.</li>



<li>Innovative Eyewear (NASDAQ:<a href="https://investorplace.com/stock-quotes/lucy-stock-quote/">LUCY</a>) stock is retreating more than 21% on a <a href="https://finance.yahoo.com/news/innovative-eyewear-inc-announces-2-184300125.html">new direct offering</a>.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) shares are tumbling over 18% without any obvious news today.</li>



<li>SCWorx (NASDAQ:<a href="https://investorplace.com/stock-quotes/worx-stock-quote/">WORX</a>) stock is taking a more than 16% beating this morning.</li>



<li>Salesforce (NYSE:<a href="https://investorplace.com/stock-quotes/crm-stock-quote/">CRM</a>) shares are dropping over 16% on <a href="https://finance.yahoo.com/video/salesforce-stock-sinking-q2-earnings-202330512.html">poor Q2 guidance</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) stock is decreasing close to 16% after an unexpected rally yesterday.</li>



<li>Sharps Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/stss-stock-quote/">STSS</a>) shares are falling more than 14% <a href="https://investorplace.com/2024/05/why-is-sharps-technology-stss-stock-up-194-today/">following a recent rally</a>.</li>



<li>Fangdd Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/duo-stock-quote/">DUO</a>) stock is slipping over 13% today.</li>



<li>Agilent Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/a-stock-quote/">A</a>) shares close out our pre-market stock movers down over 13% on <a href="https://finance.yahoo.com/news/agilent-reports-q2-earnings-key-220003997.html">fiscal Q2 earnings</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-may-30th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
There are risks associated with any investment &ndash; there&rsquo;s no such thing as a surefire investment, although tools like the Portfolio Grader can make your life easier when looking for stocks to buy and those to avoid. One of the riskiest investments are in F-rated <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>, and those should be avoided at all costs when you&rsquo;re considering your portfolio.



Penny stocks are low-priced securities, but they really don&rsquo;t cost a penny. Instead, they are shares of stocks that are priced at less than $5 &ndash; still a pittance compared to some of the top names in the market. While some large companies fall into penny stock territory, penny stocks often represent small, less established companies. While the low cost and potential for high returns can make penny stocks appealing to some investors, they come with significant risks, especially when dealing with F-rated penny stocks.



F-rated penny stocks represent companies that have the lowest ratings from the Portfolio Grader based on factors like earnings performance, growth, trading momentum and analyst sentiment. These ratings show poor financial health, unstable management, or dubious business practices.



Another huge issue with F-rated penny stocks is that they are volatile. You have to have a high risk tolerance because these stocks often experience significant price swings within short periods, driven by speculative trading and limited market liquidity. 



It is very difficult to predict the day-to-day price movements of penny stocks, which means a bad bet can wipe out your investment pretty quickly.



The names on this list all get &ldquo;F&rdquo; ratings in the Portfolio Grader, and should be avoided this month.



<h2>Tonix Pharmaceuticals (TNXP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/pharmaceuticals_tnxp_1600-300x169.png" alt="medicine research, pharmaceutical background, LJPC stock"><div>Source: Sisacorn / Shutterstock.com</div></div>Tonix Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/tnxp-stock-quote/">TNXP</a>) is a biopharmaceutical company based in New Jersey. The company works on created drugs and therapies to treat disorders of the central nervous system.



It currently has a drug candidate in Phase 3 testing to treat fibromyalgia, and a treatment in Phase 2 trials that would treat long Covid-19 symptoms.



But one of the challenges of investing in pharma companies is the expense. Research and development takes a lot of money, as does the clinical trials. And even after all that, there&rsquo;s never a guarantee that the drug will come to market. That&rsquo;s why investing in a penny pharma stock is particularly dangerous.



Tonix stock fell by 40% in June when it announced a <a href="https://investorplace.com/2024/06/why-is-tonix-pharmaceuticals-tnxp-stock-down-40-today/">proposed public offering</a> to raise money for its continued funding. Investors don&rsquo;t like it when their stock is diluted, andthis is the second time. Tonix also completed a 1-for-32 reverse stock split in June to try oto keep the stock price up.



Even when that reverse split, TNXP stock is barely over $1 per share again. The stock is down 91% this year and gets an &ldquo;F&rdquo; rating in the Portfolio Grader.



<h2>Nauticus Robotics (KITT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers-300x169.jpg" alt="Image of a penny held between two fingers with a white indoor background. Dividend-Paying Penny Stocks"><div>Source: Shutterstock</div></div>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) is an interesting penny stock. The company makes underwater robots and software that is used by energy, aquaculture and security systems.



Nauticus markets itself as a solution that can help companies manage and maintain offshore wind farms. It says that its robots reduces the need for divers and topside personnel.



But being an interesting company and being a good investment doesn&rsquo;t go hand-in-hand. Nauticus only has a market capitalization of $15 million, and a stock price of roughly 15 cents per share. 



That&rsquo;s why the board held a <a href="https://ir.nauticusrobotics.com/sec-filings/all-sec-filings">special meeting on June 17</a> in which it increased the number of unissued common stock shares from 625 million to 5 billion shares. And it also got shareholders to sign off on a reverse stock split that could be as little as 1-to-6 or as much as 1-to-70 shares.



KITT stock popped briefly on the news before returning to its depressed levels. Meanwhile, earnings results for the first quarter showed only $500,000 in revenue compared to $2.8 million a year ago. 



The adjusted net loss was $7.4 million for the quarter, which was an improvement from the first quarter a year ago when it lost $10.7 million.



KITT is in rough shape, down 78% this year. It gets an &ldquo;F&rdquo; rating in the Portfolio Grader.



<h2>Mullen Automotive (MULN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/muln_mullen_1600-300x169.png" alt="The Mullen (MULN) Five vehicle is displayed at the 2021 LA Auto Show media day in Los Angeles, November, 18, 2021."><div>Source: Ringo Chiu / Shutterstock.com</div></div>I&rsquo;ve been pretty hard on Mullen Automotive (NASDAQ:<a href="https://investorplace.com/stock-quotes/muln-stock-quote/">MULN</a>), which is an electric vehicle company that&rsquo;s struggling to gain relevance. 



I wasn&rsquo;t impressed in 2023 when the company enacted three reverse stock splits, including a 1-for-100 split in December, just so it could remain listed on the Nasdaq.



But Mullen is making a legitimate effort to remake its business by becoming a manufacturer of commercial EVs. It signed a new deal to supply 40 commercial vehicles to a company in&nbsp;<a href="https://finance.yahoo.com/news/mullen-automotive-secures-major-european-183010622.html">Switzerland</a>.&nbsp;It also signed a franchise <a href="https://seekingalpha.com/news/4114510-mullen-enters-new-dealership-and-gets-initial-order?source=content_type%3Areact%7Cfirst_level_url%3Amarket-news%7Csection_asset%3Amain">agreement</a> with Eco Auto, a dealership located in Boston, that&rsquo;s focused on EVs.



I appreciate that Mullen is trying to salvage some value. It invoiced $16.3 million in vehicles in the second quarter of fiscal 2024. But losses are still massive, with a net loss of the quarter of $235.3 million and a cash burn of $120 million.



MULN stock is down 82% this year and gets an &ldquo;F&rdquo; rating in the Portfolio Grader.



<h2>Avalon GloboCare (ALBT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-finding-magnify-300x169.jpg" alt="A hand holding a magnifying glass over pennies. under-$1 stocks to buy. penny stocks to buy"><div>Source: Shutterstock</div></div>Avalon GloboCare (NASDAQ:<a href="https://investorplace.com/stock-quotes/albt-stock-quote/">ALBT</a>) is a biotechnology company that develops diagnostic and clinical laboratory products. It&rsquo;s working on a commercial Breathalyzer system that would be a handheld device that can detect acetone levels.



It also has a research project with the Massachusetts Institute of Technology to create a QTY code protein design platform.



The advancements are interesting, but the company has some issues at well. In May it got warning from Nasdaq that as of May 22, the company had not yet filed its first quarter report. <a href="https://www.avalon-globocare.com/investors/sec-filings/quarterly-reports">When the report finally came out</a>, it showed a net loss of $1.36 million, or 12 cents per share, versus a loss of $2.91 million and 29 cents per share in the same quarter a year ago.



Avalon has just over $300,000 in cash on hand, so it will have to be careful with its finances if its going to complete its projects.



ALBT stock is down 14% this year and gets an &ldquo;F&rdquo; rating in the Portfolio Grader.



<h2>ChargePoint Holdings (CHPT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/04/chpt-stock-2-300x169.jpg" alt="EV stocks: A close-up shot of a ChargePoint charging station."><div>Source: YuniqueB / Shutterstock.com</div></div>ChargePoint Holdings (NYSE:<a href="https://investorplace.com/stock-quotes/chpt-stock-quote/">CHPT</a>) is a good company with a good idea and it simply got outplayed. 



The Biden administration is all-in on building out the national infrastructure to power electric vehicles, and it made perfectly good sense for a company like ChargePoint to be in the forefront of making that happen.



But then there&rsquo;s Tesla (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>). Tesla has more than 40,000 charging stations and a powerful automotive company that has a vested interest in getting as many charging stations out there as possible. Tesla&rsquo;s charging stations are all branded with the company&rsquo;s name of course, making them a valuable marketing and advertising tool that just makes Tesla stronger.



Tesla also gets billions of dollars a year by partnering with other automotive companies so they can use the Tesla network.



Where does that leave ChargePoint? Not in a good place. <a href="https://s22.q4cdn.com/779683160/files/doc_financials/2024/2025/q1/CHPT_FY2025-Q1_FINAL.pdf">Earnings</a> for the first quarter of fiscal 2025 showed revenue of $107 million, down 18% from a year ago. The company posted a net loss of $71.8 million, which was a 10% improvement from last year.



On Penny Stocks and Low-Volume Stocks:&#8239;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>



On the date of publication, neither Louis&nbsp;Navellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/market360/2024/06/7-f-rated-penny-stocks-to-avoid-this-june/">7 F-Rated Penny Stocks to Avoid This June</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 F-Rated Penny Stocks to Avoid This June

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Molecular Templates (NASDAQ:<a href="https://investorplace.com/stock-quotes/mtem-stock-quote/">MTEM</a>) just reported results for the second quarter of 2024.<ul><li>Molecular Templates reported earnings per share of -$1.23. This was above the analyst estimate for EPS of -$1.44.</li><li>The company reported revenue of $572,000.</li><li>This was 33.02% better than the analyst estimate for revenue of $430,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/mtem-stock-earnings-molecular-templates-for-q2-of-2024/">MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

MTEM Stock Earnings: Molecular Templates Beats EPS, Beats Revenue for Q2 2024

Molecular Templates GAAP EPS of -$1.23 misses by $0.12, revenue of $0.6M beats by $0.27M

Bristol, Prime Medicine in deal to develop T-cell therapies

ALBT

BURL

CHPT

FCEL

HLTH

KITT

KTRA

LUCY

MULN

ONCO

ONMD

PATH

PRME

SMFL

SNOA

STSS

TNXP

TSLA

WORX

Health Care

Press Releases

Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid Tumors

Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update

Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Molecular Templates, Inc. Provides Interim Update

Financing

Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer Patients Observed Through Novel Immuno-oncology Mechanism

Molecular Templates, Inc. Reports First Quarter  2024 Financial Results and Corporate Update

Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Alzamend Neuro

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

Avalo Therapeutics

BioCardia

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

BioVie

Calidi Biotherapeutics, Inc. Common Stock

Calidi Biotherapeutics

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

Carmell

Galecto

GlycoMimetics

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kintara Therapeutics, Inc. - Common Stock

Kintara Therapeutics

Mustang Bio

Mainz Biomed

NKGen Biotech

Portage Biotech

Plus Therapeutics

Soligenix

Senti Biosciences

Turnstone Biologics

Viracta Therapeutics, Inc. - Common Stock

Comments

Molecular Templates

Interés en corto

Molecular Templates (NASDAQ:MTEM) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL